Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.

Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz HI, Minden K, Onel K, Zemel L, Martin A, Koné-Paut I, Siamopoulou-Mavridou A, Silva CA, Porter-Brown B, Bharucha KN, Brunner HI, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

J Rheumatol. 2019 Sep;46(9):1117-1126. doi: 10.3899/jrheum.180795. Epub 2019 Mar 1.

2.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

PMID:
30225949
3.

Acute Hemorrhagic Edema of Infancy With Associated Hemorrhagic Lacrimation.

Sneller H, Vega C, Zemel L, Chicaiza HP.

Pediatr Emerg Care. 2018 Aug 14. doi: 10.1097/PEC.0000000000001542. [Epub ahead of print]

PMID:
30113438
4.

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.

Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE; Juvenile Idiopathic Arthritis Disease-Specific and Uveitis Subcommittee of the Childhood Arthritis Rheumatology and Research Alliance.

Arthritis Care Res (Hoboken). 2019 Apr;71(4):482-491. doi: 10.1002/acr.23610.

PMID:
29806733
5.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH.

Arthritis Rheumatol. 2018 Sep;70(9):1508-1518. doi: 10.1002/art.40509. Epub 2018 Jul 25.

6.

Juvenile Fibromyalgia: A Primary Pain, or Pain Processing, Disorder.

Zemel L, Blier PR.

Semin Pediatr Neurol. 2016 Aug;23(3):231-241. doi: 10.1016/j.spen.2016.10.007. Epub 2016 Oct 14. Review.

PMID:
27989331
7.

Preliminary Outcomes of a Cross-Site Cognitive-Behavioral and Neuromuscular Integrative Training Intervention for Juvenile Fibromyalgia.

Tran ST, Guite JW, Pantaleao A, Pfeiffer M, Myer GD, Sil S, Thomas SM, Ting TV, Williams SE, Edelheit B, Ounpuu S, Rodriguez-MacClintic J, Zemel L, Zempsky W, Kashikar-Zuck S.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):413-420. doi: 10.1002/acr.22946.

8.

The effects of celecoxib or naproxen on blood pressure in pediatric patients with juvenile idiopathic arthritis.

Falkner B, Berger M, Bhadra Brown P, Iorga D, Nickeson RW, Zemel L.

Clin Med Insights Pediatr. 2015 May 4;9:55-62. doi: 10.4137/CMPed.s20720. eCollection 2015.

9.

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE, Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.

Arthritis Rheumatol. 2014 Sep;66(9):2570-9. doi: 10.1002/art.38699.

10.

Selection of peptides binding to metallic borides by screening M13 phage display libraries.

Ploss M, Facey SJ, Bruhn C, Zemel L, Hofmann K, Stark RW, Albert B, Hauer B.

BMC Biotechnol. 2014 Feb 10;14:12. doi: 10.1186/1472-6750-14-12.

11.

Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.

Martillotti J, Moote D, Zemel L.

Pediatr Radiol. 2014 Jan;44(1):115-8. doi: 10.1007/s00247-013-2738-6. Epub 2013 Jul 10.

PMID:
23839717
12.

Monitoring the HIV-1 integrase enzymatic activity using atomic force microscopy in a 2LTR system.

Guy S, Rotem D, Hayouka Z, Gabizon R, Levin A, Zemel L, Loyter A, Porath D, Friedler A.

Chem Commun (Camb). 2013 Apr 18;49(30):3113-5. doi: 10.1039/c3cc40748a. Epub 2013 Mar 6.

PMID:
23463374
13.

Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies.

Henderson LA, Loring SH, Gill RR, Liao KP, Ishizawar R, Kim S, Perlmutter-Goldenson R, Rothman D, Son MB, Stoll ML, Zemel LS, Sandborg C, Dellaripa PF, Nigrovic PA.

J Rheumatol. 2013 Mar;40(3):273-81. doi: 10.3899/jrheum.121048. Epub 2013 Feb 1.

14.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. Erratum in: N Engl J Med. 2015 Feb 26;372(9):887.

15.

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

Ilowite NT, Sandborg CI, Feldman BM, Grom A, Schanberg LE, Giannini EH, Wallace CA, Schneider R, Kenney K, Gottlieb B, Hashkes PJ, Imundo L, Kimura Y, Lang B, Miller M, Milojevic D, O'Neil KM, Punaro M, Ruth N, Singer NG, Vehe RK, Verbsky J, Woodward A, Zemel L.

Pediatr Rheumatol Online J. 2012 Aug 29;10(1):31. doi: 10.1186/1546-0096-10-31.

16.

Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York.

Feder HM Jr, Hoss DM, Zemel L, Telford SR 3rd, Dias F, Wormser GP.

Clin Infect Dis. 2011 Nov;53(10):e142-6. doi: 10.1093/cid/cir553. Epub 2011 Sep 21.

PMID:
21940418
17.

A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.

Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ.

J Rheumatol. 2009 Jan;36(1):174-82. doi: 10.3899/jrheum.080073.

PMID:
19012356
18.

Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.

Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2008 Feb 15;59(2):214-21. doi: 10.1002/art.23340.

19.

A critical appraisal of "chronic Lyme disease".

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L.

N Engl J Med. 2007 Oct 4;357(14):1422-30. Review. No abstract available. Erratum in: N Engl J Med. 2008 Mar 6;358(10):1084. Agger, WA [added]; Artsob, H [added]; Auwaerter, P [added]; Dumler, JS [added]; Bakken, JS [added]; Bockenstedt, LK [added]; Green, J [added]; Dattwyler, RJ [added]; Munoz, J [added]; Nadelman, RB [added]; Schwartz, I [added]; Draper, T [added]; McSweegan,.

PMID:
17914043
20.

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Rheumatology (Oxford). 2007 Oct;46(10):1606-11.

21.

Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies.

Chung YL, Rider LG, Bell JD, Summers RM, Zemel LS, Rennebohm RM, Passo MH, Hicks J, Miller FW, Scott DL; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2005 Aug 15;53(4):565-70.

22.

History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, Dyer A, Curdy DM, Vogler L, Reed A, Cawkwell G, Zemel L, Sandborg C, Rivas-Chacon R, Hom C, Ilowite N, Gedalia A, Gitlin J, Borzy M.

Arthritis Rheum. 2005 Apr 15;53(2):166-72.

23.

Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale.

Rennebohm RM, Jones K, Huber AM, Ballinger SH, Bowyer SL, Feldman BM, Hicks J, Katona IM, Lindsley CB, Miller FW, Passo MH, Perez MD, Reed AM, Wallace CA, White PH, Zemel LS, Lachenbruch PA, Hayes JR, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2004 Jun 15;51(3):365-70.

24.

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.

Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2004 May;50(5):1595-603.

25.

Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.

Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, Rennebohm R, Moore TL, Pepmueller PH, Spencer C, Wagner-Weiner L, Rabinovich E, Passo M, Lovell DJ, McCurdy D, Zemel L, Schikler KN, Szer I, Kurtin P, Lindsley C.

J Rheumatol. 2003 Feb;30(2):394-400.

PMID:
12563701
26.

Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies.

Rider LG, Schiffenbauer AS, Zito M, Lim KL, Ahmed A, Zemel LS, Rennebohm RM, Passo MH, Summers RM, Hicks JE, Lachenbruch PA, Heyes MP, Miller FW; Juvenile Dermatomyositis Disease Activity Collaboration Study Group.

Clin Chem. 2002 Oct;48(10):1681-8.

27.

Streptococcus pyogenes pyomyositis.

Zervas SJ, Zemel LS, Romness MJ, Kaplan EL, Salazar JC.

Pediatr Infect Dis J. 2002 Feb;21(2):166-8.

PMID:
11840087
28.

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Huber AM, Hicks JE, Lachenbruch PA, Perez MD, Zemel LS, Rennebohm RM, Wallace CA, Lindsley CB, Passo MH, Ballinger SH, Bowyer SL, Reed AM, White PH, Katona IM, Miller FW, Rider LG, Feldman BM; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

J Rheumatol. 2001 May;28(5):1106-11.

PMID:
11361197
29.

Lyme disease and pseudotumor.

Zemel L.

Mayo Clin Proc. 2000 Mar;75(3):315. No abstract available.

PMID:
10725963
30.

CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, Sood R, Makalowska I, Baxevanis A, Johnstone B, Laxer RM, Zemel L, Kim CA, Herd JK, Ihle J, Williams C, Johnson M, Raman V, Alonso LG, Brunoni D, Gerstein A, Papadopoulos N, Bahabri SA, Trent JM, Warman ML.

Nat Genet. 1999 Nov;23(3):319-22.

PMID:
10545950
31.

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, Hicks JE, Levinson JE, Mier R, Pachman LM, Passo MH, Perez MD, Reed AM, Schikler KN, Smith M, Zemel LS, Rider LG.

Arthritis Rheum. 1999 Oct;42(10):2213-9.

32.

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.

Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB.

Arthritis Rheum. 1999 Sep;42(9):1833-42.

33.

Lyme arthritis in children: clinical epidemiology and long-term outcomes.

Gerber MA, Zemel LS, Shapiro ED.

Pediatrics. 1998 Oct;102(4 Pt 1):905-8.

PMID:
9755263
34.

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, Wallace CA, Ballinger SH, Bowyer SL, Reed AM, Passo MH, Katona IM, Miller FW, Lachenbruch PA.

Arthritis Rheum. 1997 Nov;40(11):1976-83.

PMID:
9365086
35.

Interpretation of immunoblot in pediatric Lyme arthritis.

Sood SK, Zemel LS, Ilowite NT.

J Rheumatol. 1995 Apr;22(4):758-61.

PMID:
7791177
36.

Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.

Silverman ED, Cawkwell GD, Lovell DJ, Laxer RM, Lehman TJ, Passo MH, Zemel LS, Giannini EH.

J Rheumatol. 1994 Dec;21(12):2353-8.

PMID:
7699642
37.

Lyme disease--a pediatric perspective.

Zemel LS.

J Rheumatol Suppl. 1992 Jul;34:1-13. Review. No abstract available.

PMID:
1527779
38.

Babesiosis: an underdiagnosed disease of children.

Krause PJ, Telford SR 3rd, Pollack RJ, Ryan R, Brassard P, Zemel L, Spielman A.

Pediatrics. 1992 Jun;89(6 Pt 1):1045-8.

PMID:
1594345
39.
40.

Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.

Giannini EH, Barron KS, Spencer CH, Person DA, Baum J, Bernstein BH, Kredich DW, Jacobs JC, Zemel LS, Gibbas D, et al.

J Rheumatol. 1991 Aug;18(8):1240-2.

PMID:
1941832
41.

5,5'-Diphenylhydantoin decreases the entry of 3,5,3'-triiodo-L-thyronine but not L-thyroxine in cultured GH-producing cells.

Zemel LR, Biezunski DR, Shapiro LE, Surks MI.

Acta Endocrinol (Copenh). 1988 Mar;117(3):392-8.

PMID:
3381641
42.

Unilateral Raynaud's symptoms evoked during dream report.

Szajnberg NM, Zalneraitis E, Zemel L.

Lancet. 1987 Oct 3;2(8562):802. No abstract available.

PMID:
2889019
43.

Transient synovitis of the hip.

Zemel L.

J Pediatr Orthop. 1986 Nov-Dec;6(6):755. No abstract available.

PMID:
3793899
44.

Chronic arthritis of the knee in Lyme disease. Review of the literature and report of two cases treated by synovectomy.

McLaughlin TP, Zemel L, Fisher RL, Gossling HR.

J Bone Joint Surg Am. 1986 Sep;68(7):1057-61.

PMID:
3745243

Supplemental Content

Support Center